Panacea Biotec has informed that about the launch of Paclitaxel Protein-Based Particles for Injectable Suspension (Albumin - Bound), a generic version of Abraxane in the Canadian market by its material wholly-owned subsidiary company viz. Panacea Biotec Pharma through its strategic partner Apotex Inc., Canada.
The above information is a part of company’s filings submitted to BSE.